The benefits of looking across many cancer genomes

Cancer is not a single entity, but rather, it is more than one hundred complex and distinct diseases, with most cancer types demanding a unique treatment strategy. This understanding led, in part, to the launch of The Cancer Genome Atlas, a joint venture supported by the National Cancer Institute and the National Human Genome Research Institute. Read more here.